India
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 544.75 M
|
March 31, 2024 | USD 17.54 | 2.44% |
|
India |
|
2 |
USD 46.94 M
|
March 31, 2024 | USD 1.80 | -0.88% |
|
India |
|
3 |
USD 20.81 M
|
March 31, 2024 | USD 7.01 | -1.64% |
|
India |
|
4 |
USD 19.02 M
|
March 31, 2024 | USD 2.73 | -5.50% |
|
India |
|
5 |
USD 11.32 M
|
March 31, 2024 | USD 1.50 | 0.58% |
|
India |
|
6 |
USD 9.95 M
|
March 31, 2024 | USD 0.21 | -0.24% |
|
India |
|
7 |
USD 9.18 M
|
March 31, 2024 | USD 0.18 | -0.18% |
|
India |
|
8 |
USD 7.84 M
|
March 31, 2024 | USD 30.65 | -0.51% |
|
India |
|
9 |
USD 6.04 M
|
March 31, 2024 | USD 8.31 | -0.73% |
|
India |
|
10 |
USD 4.56 M
|
March 31, 2024 | USD 2.46 | -3.28% |
|
India |
|
11 |
USD 4.50 M
|
Dec. 31, 2023 | USD 62.31 | -1.11% |
|
India |
|
12 |
USD 2.61 M
|
March 31, 2024 | USD 86.68 | -0.08% |
|
India |
|
13 |
USD 1.23 M
|
March 31, 2024 | USD 4.72 | -3.66% |
|
India |
|
14 |
USD 144.19 K
|
March 31, 2024 | USD 0.19 | -2.01% |
|
India |
|
15 |
USD 39.88 K
|
March 31, 2024 | USD 0.56 | -2.22% |
|
India |
|
16 |
USD -332.13 K
|
March 31, 2024 | USD 0.89 | -0.41% |
|
India |
|
17 |
USD -420.81 K
|
March 31, 2024 | USD 6.08 | -1.96% |
|
India |
|
18 |
USD -824.40 K
|
June 30, 2024 | USD 61.88 | 0.14% |
|
India |
|
19 |
USD -864.32 K
|
March 31, 2024 | USD 4.11 | 2.19% |
|
India |
|
20 |
USD -894.62 K
|
March 31, 2024 | USD 0.13 | -2.33% |
|
India |
|
21 |
USD -937.14 K
|
March 31, 2024 | USD 1.17 | 4.72% |
|
India |
|
22 |
USD -1.14 M
|
March 31, 2024 | USD 3.72 | 1.96% |
|
India |
|
23 |
USD -1.35 M
|
March 31, 2024 | USD 7.46 | -6.17% |
|
India |
|
24 |
USD -1.42 M
|
March 31, 2024 | USD 1.29 | 1.61% |
|
India |
|
25 |
USD -1.55 M
|
March 31, 2024 | USD 11.19 | -2.25% |
|
India |
|
26 |
USD -1.60 M
|
March 31, 2024 | USD 1.31 | -1.18% |
|
India |
|
27 |
USD -1.80 M
|
March 31, 2024 | USD 0.92 | 0.91% |
|
India |
|
28 |
USD -1.91 M
|
March 31, 2024 | USD 2.64 | -2.39% |
|
India |
|
29 |
USD -1.99 M
|
March 31, 2024 | USD 2.76 | -0.96% |
|
India |
|
30 |
USD -2.04 M
|
March 31, 2024 | USD 0.43 | 4.43% |
|
India |
|
31 |
USD -2.05 M
|
March 31, 2024 | USD 5.38 | -1.58% |
|
India |
|
32 |
USD -2.21 M
|
March 31, 2024 | USD 14.35 | -1.03% |
|
India |
|
33 |
USD -2.91 M
|
March 31, 2024 | USD 32.02 | -0.02% |
|
India |
|
34 |
USD -2.94 M
|
March 31, 2024 | USD 3.04 | -2.74% |
|
India |
|
35 |
USD -3.22 M
|
March 31, 2024 | USD 21.49 | -6.41% |
|
India |
|
36 |
USD -3.60 M
|
March 31, 2024 | USD 56.38 | -2.07% |
|
India |
|
37 |
USD -4.07 M
|
March 31, 2024 | USD 3.34 | 4.09% |
|
India |
|
38 |
USD -5.22 M
|
March 31, 2024 | USD 2.08 | -3.10% |
|
India |
|
39 |
USD -6.18 M
|
March 31, 2024 | USD 3.13 | -1.64% |
|
India |
|
40 |
USD -6.24 M
|
March 31, 2024 | USD 2.48 | 0.36% |
|
India |
|
41 |
USD -6.87 M
|
March 31, 2024 | USD 8.53 | -1.99% |
|
India |
|
42 |
USD -7.75 M
|
March 31, 2024 | USD 3.77 | -3.91% |
|
India |
|
43 |
USD -8.75 M
|
March 31, 2024 | USD 1.22 | 0.46% |
|
India |
|
44 |
USD -9.01 M
|
March 31, 2024 | USD 49.62 | -1.53% |
|
India |
|
45 |
USD -9.10 M
|
March 31, 2024 | USD 18.08 | -4.77% |
|
India |
|
46 |
USD -9.12 M
|
March 31, 2024 | USD 11.74 | -1.33% |
|
India |
|
47 |
USD -9.49 M
|
March 31, 2024 | USD 28.42 | -1.59% |
|
India |
|
48 |
USD -9.93 M
|
March 31, 2024 | USD 9.07 | -2.14% |
|
India |
|
49 |
USD -9.99 M
|
March 31, 2024 | USD 0.70 | -2.55% |
|
India |
|
50 |
USD -10.16 M
|
March 31, 2024 | USD 25.14 | -2.56% |
|
India |
The Healthcare company in India with the highest Net Cash Used For Investing Activities is Glenmark Pharmaceuticals Limited (NSE: GLENMARK.NS) at USD 544.75 M.
The Healthcare company in India with the lowest Net Cash Used For Investing Activities is Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) at USD -543.92 M.
The top 10 Healthcare companies in India by Net Cash Used For Investing Activities are Glenmark Pharmaceuticals Limited, Sun Pharma Advanced Research Company Limited, Hinduja Global Solutions Limited, Max India Limited, Suven Life Sciences Limited, Syncom Formulations (India) Limited, Ind-Swift Limited, Ajanta Pharma Limited, Unichem Laboratories Limited and Shalby Limited.
The bottom 10 Healthcare companies in India by Net Cash Used For Investing Activities are Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Mankind Pharma Limited, Piramal Enterprises Limited, Eris Lifesciences Limited, Gland Pharma Limited, Lupin Limited, Apollo Hospitals Enterprise Limited and Zydus Lifesciences Limited.